Article
The mutational landscape of lethal castration-resistant prostate cancer.
Nature - 12 Jul 2012
Grasso Catherine S, Wu Yi-Mi, Robinson Dan R, Cao Xuhong, Dhanasekaran Saravana M, Khan Amjad P, Quist Michael J, Jing Xiaojun, Lonigro Robert J, Brenner J Chad, Asangani Irfan A, Ateeq Bushra, Chun Sang Y, Siddiqui Javed, Sam Lee, Anstett Matt, Mehra Rohit, Prensner John R, Palanisamy Nallasivam, Ryslik Gregory A, Vandin Fabio, Raphael Benjamin J, Kunju Lakshmi P, Rhodes Daniel R, Pienta Kenneth J, Chinnaiyan Arul M, Tomlins Scott A
Abstract excerpt
Characterization of the prostate cancer transcriptome and genome has identified chromosomal rearrangements and copy number gains and losses, including ETS gene family fusions, PTEN loss and androgen receptor (AR) amplification, which drive prostate cancer development and progression to lethal, metastatic castration-resistant prostate cancer (CRPC). However, less is known about the role of mutations. Here we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
